Navigation Links
Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
Date:2/13/2008

- Company Establishes U.S. subsidiary in Philadelphia Area -

PHILADELPHIA, Feb. 13 /PRNewswire/ -- Cellvizio Inc., a leader in in vivo cellular imaging, announced today the appointment of Chris Tihansky as its President. Cellvizio Inc. is the U.S. subsidiary of Paris-based Mauna Kea Technologies and develops and markets Cellvizio(R), a fundamentally new endoscopic imaging approach which improves patient care by eliminating the need for unnecessary biopsies and enhances the diagnosis of a broad range of diseases via in vivo cellular imaging.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080213/NYW021 )

The appointment coincides with the company establishing its U.S. operations base in the Philadelphia area.

"Cellvizio is increasing its commercialization efforts in the U.S., and Chris is a great fit for leading this," said Sacha Loiseau, Ph.D., founder, president and chief executive officer of Mauna Kea. "He has a unique combination of expertise in the medical technology field, including general management, business development, sales, and product development."

"Cellvizio is an excellent example of a company that has successfully taken a cutting-edge technology from bench top to bedside," explained Chris. "I am very pleased to be leading our team in the U.S. It is our intention to make Cellvizio a standard of care so that as many patients as possible have access to the advantages this technology offers."

"The Philadelphia area is a perfect location for us to rapidly build our business," Chris stated. "It offers ready access to our customer base and a strong talent pool. Additionally, it is increasingly evident that Southeastern Pennsylvania offers a well-developed support infrastructure for emerging med- tech companies."

Chris has 20 years of experience in the emerging medical technology and healthcare financials services industries. He most recently served as President and CEO of Surgical Services Inc. (SSI), a division of Teleflex Inc. (NYSE: TFX). Chris received a Bachelor of Science Degree in Mechanical Engineering from Lehigh University in Bethlehem, PA; a Master of Science Degree in Biomedical Engineering from Drexel University in Philadelphia; and a Master of Business Administration degree from the University of San Diego.

About Mauna Kea Technologies:

Mauna Kea Technologies leads the growing in vivo cellular imaging market enabling physicians to visualize, diagnose and treat pathologies that can not be seen using other imaging techniques. Mauna Kea Technologies' flagship Cellvizio(R) system provides microscopic visualization of mucosal tissue and promises to improve clinical outcomes by increasing the diagnostic yield of existing endoscopic procedures. With over 1000 Cellvizio procedures completed to date, Mauna Kea Technologies is currently focused on the gastroenterology and pulmonology markets. The company plans to expand into other markets in the future. The company also has a distribution agreement with Leica Microsystems to sell products for the Small Animal Imaging market in Europe, the U.S. and Japan. For more information about Mauna Kea Technologies: http://www.maunakeatech.com


'/>"/>
SOURCE Cellvizio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants
2. Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
3. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
4. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
5. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
6. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
7. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
8. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
9. David Mott Appointed Non Executive Director at Shire
10. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
11. John Marshall and Kevin McGuinness Appointed to Ellex Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017 http://www.Financialbuzz.com - ... leading causes of death worldwide. There were 8.2 million ... cancer related deaths increased gradually over time, the death ... of various cancers continues to drive demand of biological ... Global Market Insights, Inc. cancer biological therapy market size was ...
(Date:1/19/2017)... Research and Markets has announced the addition of the ... Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their ... Cancer ... reach $15,737 million by 2022 from $6,521 in 2015, growing at ... Omic technologies segment accounted for more than half of the revenue ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... announced the formation of its Medical/Clinical Advisory Board. ... industry veterans who enhance the range and depth ... development of its novel prenatal diagnostic tests.  These ... and strategic guidance for the company,s product development ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the "Implantable Biomaterials ... report to their offering. Report Highlights: ... detailed analysis on current and future market trends to identify the investment ... as the base numbers Key market trends across the ...
Breaking Biology Technology:
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
Breaking Biology News(10 mins):